Stellar Biotechnologies (SBOT) Stock Price Up 10.9%

Stellar Biotechnologies Inc (NASDAQ:SBOT)’s share price rose 10.9% during mid-day trading on Friday . The company traded as high as $1.14 and last traded at $1.12. Approximately 559,637 shares traded hands during mid-day trading, an increase of 34% from the average daily volume of 417,659 shares. The stock had previously closed at $1.01.

Separately, ValuEngine upgraded shares of Stellar Biotechnologies from a “hold” rating to a “buy” rating in a research report on Thursday, November 1st.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at

About Stellar Biotechnologies (NASDAQ:SBOT)

Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market.

Read More: Moving Average – How it Helps Investors in Stock Selection

Receive News & Ratings for Stellar Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellar Biotechnologies and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit